BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8636257)

  • 1. Impaired processing of proopiomelanocortin in corticotroph macroadenomas.
    Gibson S; Ray DW; Crosby SR; Dornan TL; Jennings AM; Bevan JS; Davis JR; White A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):497-502. PubMed ID: 8636257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of adrenocorticotropin (ACTH) precursors in post-adrenalectomy Cushing's disease and their regulation by glucocorticoids.
    Ray DW; Gibson S; Crosby SR; Davies D; Davis JR; White A
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2430-6. PubMed ID: 7629238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
    Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
    J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
    Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
    J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
    Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
    Endocrine; 2017 Mar; 55(3):853-860. PubMed ID: 27220856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma immunoreactive joining peptide in man: a new marker of proopiomelanocortin processing and corticotroph function.
    Phlipponneau M; Lenne F; Proeschel MF; Girard F; Luton JP; Bertagna X
    J Clin Endocrinol Metab; 1993 Feb; 76(2):325-9. PubMed ID: 8381797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay.
    Crosby SR; Stewart MF; Ratcliffe JG; White A
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1272-7. PubMed ID: 2848055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
    Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
    J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTH precursors characterize the ectopic ACTH syndrome.
    Stewart PM; Gibson S; Crosby SR; Penn R; Holder R; Ferry D; Thatcher N; Phillips P; London DR; White A
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):199-204. PubMed ID: 8137518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
    Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
    Bertagna X
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of ACTH related peptides in ectopic Cushing's syndrome.
    Oliver RL; Davis JR; White A
    Pituitary; 2003; 6(3):119-26. PubMed ID: 14971736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal insufficiency after incomplete resection of pituitary macrocorticotropinoma of Cushing's disease: role of high molecular weight ACTH.
    Yamakita N; Murai T; Oki Y; Matsuhisa T; Hirata T; Ikeda T; Kuwayama A; Yasuda K
    Endocr J; 2001 Feb; 48(1):43-51. PubMed ID: 11403102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.